John Overdeck Two Sigma Investments
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$510M |
| 2 |
Broadcom
AVGO
|
+$318M |
| 3 |
Marvell Technology
MRVL
|
+$290M |
| 4 |
Salesforce
CRM
|
+$263M |
| 5 |
Advanced Micro Devices
AMD
|
+$250M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$255M |
| 2 |
Progressive
PGR
|
+$244M |
| 3 |
Visa
V
|
+$238M |
| 4 |
Lam Research
LRCX
|
+$201M |
| 5 |
Elevance Health
ELV
|
+$190M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.88% |
| 2 | Healthcare | 13.28% |
| 3 | Financials | 10.32% |
| 4 | Industrials | 9.79% |
| 5 | Consumer Discretionary | 8.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1076
TeraWulf
WULF
$7.72B
| $5.05M | 0.01% |
1,850,324
+1,308,898
| +242% | +$5.83M |
|
|
VRNA
1077
DELISTED
Verona Pharma
VRNA
| $5.03M | 0.01% |
79,211
-72,893
| -48% | -$4.36M |
|
1078
Warby Parker
WRBY
$3.24B
| $5.01M | 0.01% |
274,639
+32,057
| +13% | +$765K |
|
|
PLMK
1079
Plum Acquisition Corp IV
PLMK
$114M
| $5M | 0.01% |
+498,437
| New | +$4.99M |
|
1080
Parker-Hannifin
PH
$128B
| $5M | 0.01% |
8,227
-2,304
| -22% | -$1.51M |
|
1081
Knife River
KNF
$3.61B
| $4.99M | 0.01% |
55,329
-47,769
| -46% | -$4.65M |
|
1082
Heartland Express
HTLD
$967M
| $4.98M | 0.01% |
540,440
+125,584
| +30% | +$1.33M |
|
1083
Hain Celestial
HAIN
$75.8M
| $4.98M | 0.01% |
1,199,981
+207,918
| +21% | +$929K |
|
1084
Ardelyx
ARDX
$966M
| $4.96M | 0.01% |
1,010,138
-131,639
| -12% | -$707K |
|
1085
Albany International
AIN
$1.66B
| $4.96M | 0.01% |
71,823
+42,673
| +146% | +$3.32M |
|
1086
Adient
ADNT
$1.46B
| $4.95M | 0.01% |
384,529
+231,544
| +151% | +$3.72M |
|
1087
AnaptysBio
ANAB
$1.73B
| $4.94M | 0.01% |
265,858
-86,176
| -24% | -$1.44M |
|
1088
Inter&Co
INTR
$2.45B
| $4.94M | 0.01% |
901,220
+428,421
| +91% | +$2.22M |
|
1089
VanEck BDC Income ETF
BIZD
$1.71B
| $4.92M | 0.01% |
293,400
-56,900
| -16% | -$972K |
|
1090
CVB Financial
CVBF
$3.95B
| $4.91M | 0.01% |
266,179
+129,973
| +95% | +$2.59M |
|
1091
Amplify Junior Silver Miners ETF
SILJ
$4.23B
| $4.91M | 0.01% |
405,300
+37,200
| +10% | +$420K |
|
1092
Valley National Bancorp
VLY
$7.79B
| $4.91M | 0.01% |
552,123
+132,808
| +32% | +$1.26M |
|
|
HDRN
1093
Hadron Energy
HDRN
$134M
| $4.9M | 0.01% |
483,905
| – | – |
|
1094
Sportradar
SRAD
$3.88B
| $4.89M | 0.01% |
226,393
-307,877
| -58% | -$6.42M |
|
1095
Xeris Biopharma Holdings
XERS
$1.59B
| $4.89M | 0.01% |
+890,337
| New | +$3.59M |
|
1096
Community Health Systems
CYH
$424M
| $4.89M | 0.01% |
1,809,625
-133,338
| -7% | -$415K |
|
|
LX
1097
LexinFintech Holdings
LX
$214M
| $4.88M | 0.01% |
483,385
-1,473,974
| -75% | -$12.4M |
|
1098
ProShares Ultra VIX Short-Term Futures ETF
UVXY
$292M
| $4.87M | 0.01% |
41,587
+806
| +2% | +$83.3K |
|
1099
Gilead Sciences
GILD
$182B
| $4.86M | 0.01% |
43,400
-196,562
| -82% | -$20.3M |
|
1100
CenterPoint Energy
CNP
$25.8B
| $4.85M | 0.01% |
133,951
+38,551
| +40% | +$1.29M |
|
Similar funds
John Overdeck's Q1 2025 Portfolio in Review
As of Q1 2025, John Overdeck held 3,617 positions worth $46.8B, up 2% from $45.9B the previous quarter. Its ten largest holdings account for 8.1% of the portfolio.
John Overdeck deployed $2.08B of net new capital in Q1 2025, opening 458 new positions and adding to 1,225 existing holdings. Its largest new stake was Advanced Micro Devices: 2,246,952 shares worth $231M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 16% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Eli Lilly, an estimated $255M trimmed.
- John Overdeck's largest Q1 2025 buy was Advanced Micro Devices: 2,246,952 shares worth $231M.
- John Overdeck added most to State Street SPDR S&P 500 ETF Trust in Q1 2025, an estimated $510M increase.
- John Overdeck's biggest Q1 2025 reduction was Eli Lilly, cutting an estimated $255M.
- John Overdeck fully exited Coinbase in Q1 2025, selling an estimated $45M.
- John Overdeck's ten largest holdings make up 8.1% of its $46.8B portfolio in Q1 2025.
- John Overdeck opened 458 new positions and closed 452 in Q1 2025.
- John Overdeck's portfolio value rose 2% quarter-over-quarter to $46.8B.
Based on Two Sigma Investments's 13F filing for Q1 2025, filed 15 May 2025.